Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
---|
12/20/2001 | CA2410229A1 Vaccine for congenital tremors in pigs |
12/20/2001 | CA2409315A1 Protein phosphatases |
12/19/2001 | EP1164192A1 Sorbitol dehydrogenase, gene encoding the same and use thereof |
12/19/2001 | EP1164189A1 Method for cloning and producing the RsaI restriction endonuclease in E.coli |
12/19/2001 | EP1163353A2 Maize ku80 homolog and uses thereof |
12/19/2001 | EP1163351A1 Chimeric promoters based on the plastocyanin pete promoter from pea |
12/19/2001 | EP1163350A1 Polynucleotides for mutagenesis in fungus comprising a functional gene in magnaporthe and an impala tranposon |
12/19/2001 | EP1163347A2 Zwittermicin a biosynthetic gene from bacillus cereus |
12/19/2001 | EP1163346A1 Hybrid synthetase, hybrid peptide and composition containing same |
12/19/2001 | EP1163345A1 Fungal beta-tubulin genes |
12/19/2001 | EP1163344A1 Hyphal growth in fungi |
12/19/2001 | EP1163342A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
12/19/2001 | EP1163338A2 HUMAN MESENCHYMAL DNAs AND EXPRESSION PRODUCTS |
12/19/2001 | EP1163336A2 Vertebrate protein slit, dna sequence encoding it and uses thereof |
12/19/2001 | EP1163335A1 MATERIALS AND METHODS RELATING TO MODULATION OF p66 EXPRESSION |
12/19/2001 | EP1163334A1 Polynucleotide and deduced amino acid sequences from stromal cells |
12/19/2001 | EP1163332A1 48 human secreted proteins |
12/19/2001 | EP1163331A1 50 human secreted proteins |
12/19/2001 | EP1163327A1 Human protein kinase b gamma polypeptides and a method for disrupting protein kinase b gamma in a non-human |
12/19/2001 | EP1163325A1 Expression of proteolytic enzymes in koji mold in the presence of carbon sources |
12/19/2001 | EP1163323A1 Biotechnological method for producing n-acetyl mannosamine |
12/19/2001 | EP1163269A1 ISOFORMS OF MOUSE SEROTONIN 5-HT2c RECEPTOR |
12/19/2001 | EP1163267A1 47 human secreted proteins |
12/19/2001 | EP1163266A2 Barley gene for thioredoxin and nadp-thioredoxin reductase |
12/19/2001 | EP1163260A1 Process for partitioning of proteins |
12/19/2001 | EP1163255A1 50 human secreted proteins |
12/19/2001 | EP1163103A2 Surface and its manufacture and uses |
12/19/2001 | EP1162986A1 Lactobacillus strains preventing diarrhoea caused pathogenic bacteria |
12/19/2001 | EP1028933B1 Flowable multicomponent mixtures for promoting the growth of the soil micro-organism flora, and use of the same |
12/19/2001 | EP0858510B1 Process for preparing o-acetylserine, l-cysteine and l-cysteine-related products |
12/19/2001 | EP0758387B1 Thymidine kinase mutants |
12/19/2001 | EP0701570B1 Thermoresistant alpha-1-antitrypsin mutein |
12/19/2001 | EP0623215B1 Methods and compositions for diagnosing cat scratch disease and bacillary angiomatosis |
12/19/2001 | EP0493581B1 Recombinant gene coding for a protein having an endochitinase activity |
12/19/2001 | CN1327481A Automatic DNA purificating apparatus |
12/19/2001 | CN1327476A Cleaning compositions comprising multily-substituted protease variants and amylase variants |
12/19/2001 | CN1327452A Fibroblast growth factor with hepatocyte proliferation activity |
12/19/2001 | CN1327449A Human cervical cancer 1 protooncogene and protein encoded therein |
12/19/2001 | CN1327052A Process for preparing immobilized cell |
12/19/2001 | CN1327051A Method for producing cellulase |
12/19/2001 | CN1327049A Method for stick bacteria capable of producing L-glutaminic acid and producing 1-glutaminc acid |
12/19/2001 | CN1327048A A strain of recombined broad spectrum bacillus thuringiensis |
12/19/2001 | CN1327047A Method for cultivating variotin pecilocin with silkworm and medicinal use |
12/19/2001 | CN1327046A Process for deep fermentation control of mushroom liquid |
12/19/2001 | CN1076204C Recombinant coccidiosis vaccines |
12/18/2001 | US6331664 Genes, when expressed in a plant, can be used to create transgenic plants having altered palmitic acid oil profiles |
12/18/2001 | US6331621 Nucleotide sequences coding protein with enzymatic activity; for use in treatment of glomeronephritis, fibrosis, cirrhosis, cancer and arthritis |
12/18/2001 | US6331616 Nucleotide sequences coding viral envelope protein; for use as diagnostic tool in detection of viral infection |
12/18/2001 | US6331615 Nucleic acid molecule encoding heavy or light chain of an antibody which specifically recognizes a protein specifically recognized by monoclonal antibody 5c8 (anti-CD40 ligand) |
12/18/2001 | US6331613 Nucleotide sequences coding protein associated with cytokine activity; for use in treating allergies, autoimmune diseases and acquired immune deficiency syndrome; for preventing cell differentiation; for activating tissue regeneration |
12/18/2001 | US6331612 Bone morphogenic protein-16 (BMP-16) compositions |
12/18/2001 | US6331609 Fusion protein; for use in treatment of somatotropin defects |
12/18/2001 | US6331521 Beta-1,3-glucan synthase inhibitors; pneumocystis pneumonia infection treatment; fungicides |
12/18/2001 | US6331433 Human T cell leukemia cell line designated D1.1 |
12/18/2001 | US6331431 Vacuum device and method for isolating periplasmic fraction from cells |
12/18/2001 | US6331429 Layered nutrient solution; for use in detection and propagation of bacterial cells |
12/18/2001 | US6331425 Nucleotide sequences coding enzymatic polypeptide; for use in the diagnosis and treatment of cancer, meningitis and urogenital disorders; for sequencing preferential oligosaccharides |
12/18/2001 | US6331423 Nucleotide sequences coding polypeptide for use as human therapeutic agents that modulate kinase activity |
12/18/2001 | US6331421 Expression vector for use as tool for efficient generation of preferential enzymatic polypeptides |
12/18/2001 | US6331419 L-glutamic acid-producing bacterium and method for producing L-glutamic acid |
12/18/2001 | US6331415 Methods of producing immunoglobulins, vectors and transformed host cells for use therein |
12/18/2001 | US6331414 Preparation of human IGF via recombinant DNA technology |
12/18/2001 | US6331411 TopA |
12/18/2001 | US6331410 Polynucleotides encoding a novel pyrR homolog |
12/18/2001 | US6331401 Uses of the 5-HT4 receptor |
12/18/2001 | US6331300 Compositions for providing a chemical to a microorganism |
12/18/2001 | US6331140 Mobile genetic elements as tools for genetic modification of L. delbrueckii or L. helveticus |
12/18/2001 | CA2215531C Mutant of the erythrina caffra type inhibitor and the use of the said mutant for purifying serin proteases |
12/18/2001 | CA2045839C Cloned n-methylhydantoinase |
12/13/2001 | WO2001094952A2 Methods and compositions for modulating oxidized ldl transport |
12/13/2001 | WO2001094617A2 Protein fragment complementation assay based on beta-lactamase |
12/13/2001 | WO2001094600A2 Promoters for regulated gene expression |
12/13/2001 | WO2001094587A2 Extracellular messengers |
12/13/2001 | WO2001094585A1 Antibody molecules having specificity for human tumor necrosis factor alpha, and use thereof |
12/13/2001 | WO2001094581A1 Tumour suppressor and uses thereof |
12/13/2001 | WO2001094580A1 Novel g-protein coupled receptor |
12/13/2001 | WO2001094569A2 Corynebacterium glutamicum nucleotide sequences coding for the glbo gene |
12/13/2001 | WO2001094562A2 Cold sensitive mutant dna polymerases |
12/13/2001 | WO2001094550A2 Identification and use of molecular markers indicating cellular reprogramming |
12/13/2001 | WO2001094548A2 Hy2 family of bilin reductases |
12/13/2001 | WO2001094547A2 Molecular delivery vehicle for delivery of selected compounds to targets |
12/13/2001 | WO2001094544A2 N.bstnbi nicking endonuclease and methods for using endonucleases in single-stranded displacement amplification |
12/13/2001 | WO2001094418A2 Leader peptides for enhancing secretion of recombinant protein from a host cell |
12/13/2001 | WO2001094415A2 Nuclear hormone receptor |
12/13/2001 | WO2001094414A2 THE HUMAN VOLTAGE GATED SODIUM CHANNEL β-1A SUBUNIT AND METHODS OF USE |
12/13/2001 | WO2001094413A2 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
12/13/2001 | WO2001094391A2 Intracellular signaling proteins |
12/13/2001 | WO2001094387A2 Epididymis-specific proteins with fibronectin type ii modules |
12/13/2001 | WO2001094383A2 Mutated furin polypeptides having improved characteristics |
12/13/2001 | WO2001094380A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
12/13/2001 | WO2001094378A1 Nucleic acid sequences encoding type iii tenebrio antifreeze proteins and method for assaying activity |
12/13/2001 | WO2001093983A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
12/13/2001 | WO2001072772A3 Calcium binding regulatory subunit |
12/13/2001 | WO2001070968A3 Production of recombinant blood clotting factors in human cell lines |
12/13/2001 | WO2001059086A3 Methods and constructs for agrobacterium-mediated plant transformation |
12/13/2001 | WO2001055325A8 Nucleic acids, proteins, and antibodies |
12/13/2001 | WO2001055206A8 Nucleic acids, proteins, and antibodies |
12/13/2001 | WO2001055205A8 Nucleic acids, proteins, and antibodies |
12/13/2001 | WO2001046408A3 Molecular clones with mutated hiv gag/pol, siv gag and siv env genes |
12/13/2001 | WO2001044445A3 Human lyases and associated proteins |